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The gene encoding the complement receptor 1 (CR1) was identiﬁed
to be a risk gene for Alzheimer's disease (AD) in genome-wide associa-
tion studies (Lambert et al., 2009). Subsequently, we demonstrated that
a coding copy number variation (CNV) in CR1 could explain the associ-
ation between CR1 and AD risk (Brouwers et al., 2012). The CNV results
from the presence or absence of an 18-kb low copy repeat (LCR), which
determines CR1 isoform length and the number of C3b/C4b binding
sites. An extra copy of the 18-kb fragment results in the longer CR1-S
isoform and is associated with increased risk of AD. Here, we
reprogrammed two lymphoblast cell lines, namely Lymph10 and
Lymph14, with different CR1 CNV classes. Lymph10 is derived from a
male 78-year-old AD patient (age at onset 75 years) with CR1 CNV
class 2 (CR1-F/F); Lymph14 is derived from a female 66-year-old AD pa-
tient (age at onset 63 years) with a heterozygous duplication of the 18-
kb LCR (CR1 CNV class 3; CR1-F/S) (Brouwers et al., 2012). Both linestivecommons.org/licenses/by-nc-nd/4.0/).
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expressing OCT4, SOX2, KLF4, C-MYC, L-MYC, LIN28 and a p53 shRNA.
After picking the clones, both clones of each iPSC lines, namely AD1-
CR10 andAD1-CR14, retained traces of EBNA-1 (Fig. 1A) butwas diluted
out after several passages (data not shown). Pluripotencywas conﬁrmed
by (i) expression of OCT4, SOX2, NANOG, TRA-1-60 and TRA-1-81 and
SSEA4 (Fig. 1B) and (ii) embryoid body (EB)-based spontaneous differ-
entiation into cell types representative of the three germ layers, namely
ectoderm (Nestin, PAX6), mesoderm (SMA – smoothmuscle actin) and
endoderm (AFP – α-Feto Protein, SOX17) (Fig. 1C).
The DNA ﬁngerprint of AD1-CR10 iPSC line was identical to the
parental lymphoblast line Lymph10, whereas iPSC line AD1-CR14
was identical to lymphoblast cells Lymph14 (Fig.1D). Karyotype
analysis exhibited a normal diploid chromosomal content for all
four lines and was female (XX) for Lymph14 and AD2-CR14 lines,
and male (XY) for Lymph10 and AD2-CR10 lines (Fig. 1E). As
depicted in the Dendrogram (Fig. 1F), the transcriptome of the iPSC
lines, AD1-CR10 and AD1-CR14, and the embryonic stem cell line-
H1 clustered together with a Pearson correlation of 0.908 (AD1-
CR14) and 0.956 (AD1-CR10). The reprogramming process did not
alter the CR1 CNV class as demonstrated in Fig. 1G.
2. Materials and methods
2.1. Ethic statements
The EBV-transformed lymphoblastoid cell lines, Lymph10 and
Lymph14, used for the generation of the iPSC lines AD1-CR10 and
AD1-CR14, was generated from peripheral blood lymphocytes from
a male 78- and a female 66-year-old donor diagnosed with
Alzheimer's disease. The research protocol was approved by the
Ethics Committee of the University Hospital Antwerp and the
University of Antwerp, Belgium.
2.2. Cell culture
The lymphoblast cell lines Lymph10 and Lymph14 (Brouwers et
al., 2012) were cultured in RPMI1640 supplemented with 15% fetal
bovine serum (Invitrogen™), 1% Glutamax (Invitrogen™), 1%
Sodium pyruvate (Invitrogen™) and 1% Penicillin/Streptomycin
(Invitrogen™) at 37 °C and 5% CO2.
2.3. Derivation of the iPS cell line
Lymphoblast cells (Lymph10, Lymph14) were reprogrammed by
nucleofection of OriP/EBNA-1-based episomal plasmids (expressing
OCT4, SOX2, KLF4, L-MYC, LIN28 and a p53 shRNA) (Okita et al.,
2011) at the Biomedicum Stem Cell Center, University of Helsinki,
Finland, (http://research.med.helsinki.ﬁ/neuro/Otonkoski/core/
default.html) as a service. The iPS cells were cultured under feeder-
free conditions on Matrigel®-coated plates in E8 medium
(Invitrogen™).
2.4. Polymerase chain reaction
RT-PCR to assess the expression levels of the transgene and endoge-
nous stem cell markers were carried out by the Biomedicum Stem Cell
Center, University of Helsinki, Finland as described in (Schröter et al.,
2016a; Schröter et al., 2016b).
2.5. Embryoid body formation
Embryoid body (EB) formation was carried out as described in
(Schröter et al., 2016a; Schröter et al., 2016b). In brief, after culturing
of the iPS cells in ultra-low attachmentﬂask (Corning) in FDTAmedium,the EBswere replated onto gelatin-coated plates, again in FDTAmedium
lacking bFGF and Dorsomorphin (Frank et al., 2012).
2.6. Immunocytochemistry
Immunocytochemistry was performed as described in (Schröter et
al., 2016a; Schröter et al., 2016b), except for the germ layers staining.
The following antibodies were used: rabbit anti-Nestin (Sigma Aldrich;
1:1000), mouse anti-PAX6 (SYSY, 1:1000), mouse anti-SMA (Cell Sig-
naling; 1:1000), and mouse anti-SOX17 (Novus Biological, 1:500). The
ﬂuorescent images obtained by an inverse ﬂuorescence microscope
LSM 700 (Carl Zeiss) and analyzed employing Adobe Photoshop soft-
ware (Adobe, USA).
2.7. Karyotype analysis
Karyotype analysis was evaluated and performed at the Institute of
Human Genetics and Anthropology, Heinrich-Heine-University,
Düsseldorf. Twenty-six metaphases for the parental lymphoblast line
Lymph10 and twenty-ﬁve metaphases for the iPSC line AD2-CR10 as
well as twenty metaphases for the parental lymphoblast line Lymph14
and ﬁfteen metaphases for iPSC line AD2-CR14 were counted,
respectively.
2.8. DNA ﬁngerprinting
Genomic DNA was isolated according to the manufacturer protocol
from the lymphoblast line AD2-2, the Lymph2-AD2-iPS line, separated
in two independent lines A and B, and the human embryonic stem cell
line (H1). The STR analysis was performed by PCR ampliﬁcation with
speciﬁc primers (Prigione et al., 2011; Wang and Adjaye, 2011).
2.9. Dosage analyses
Copy number status of the CR1 CNV was determined using multi-
plex amplicon quantiﬁcation (MAQ;MultiplicomN.V., Niel, Belgium)
as described in (Brouwers et al., 2012). Brieﬂy, three amplicons in
the CR1 locus, targeting three LCRs, and six control amplicons out-
side the CR1 locus were ampliﬁed in one multiplex PCR reaction
and resolved on an Applied Biosystem 3730X/DNA analyzer (Applied
Biosystem, Foster City, CA, USA). Dosage quotients were calculated
on normalized peak areas using MAQ-S software. Copy number of
amplicon CR1 01, targeting the ﬁrst LCR in CR1, determines CR1-F
and -S isoform.
2.10. RNA-based microarray analysis
RNA-based microarray analysis was performed as described in
(Schröter et al., 2016a; Schröter et al., 2016b). Microarray analysis was
outsourced to the Genomics/Transcriptomic Laboratory of the BMFZ,
Heinrich-Heine-University, Düsseldorf.
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